Cameron Turtle

Professor Cameron Turtle is a Clearbridge Chair in Cancer Immunotherapy at the University of Sydney's Faculty of Medicine and Health. He leads research in CAR-T cell therapy for hematologic malignancies, focusing on efficacy, toxicity management, and clinical outcomes. His work bridges immunology, oncology, and hematology, addressing challenges in B-cell lymphoma, acute myeloid leukemia, and chronic lymphocytic leukemia treatment. Turtle collaborates with institutions like the Charles Perkins Centre and has advised students Tamara Bock and Helen Cashman. His research has been supported by grants from the CLEARbridge Foundation and other bodies. Notable contributions include predictive models for CAR-T toxicity and studies on cytokine release syndrome. He has authored over 150 peer-reviewed articles, emphasizing translational research and clinical application.